Abstract
Introduction Bicycle spoke injuries (BSIs) in children are notorious for the presence of Salter Harris type 1 (SH1) fractures. Most patients are therefore treated with cast immobilization. However, the actual prevalence of SH1 following a BSI is unknown. In this study, we aimed to describe a cohort with radiograph-negative BSIs and to identify possible clinical predictors for SH1 which might be useful for adequate risk assessment.
Methods A retrospective cohort study was performed, including all children ≤12 years visiting our Emergency Department (ED) with a BSI. Patients without radiographic evidence of a fracture were classified as low or high level of suspicion of SH1. Multivariate logistic regression analysis was used to identify independent predictors of a high level of suspicion of SH1.
Results In total, 323 patients were included. Ninety-three patients (29%) had a proven fracture; 230 patients were radiograph-negative at first presentation. Of these, 166 patients (72%) were treated with cast immobilization. At follow-up, 32 patients (13.9%) were classified as high level of suspicion of SH1. No clinical variables were found to be predictive for SH1. Local tenderness at the lateral malleolus was associated with a high level of suspicion of SH1, however, this was not statistically significant (OR 2.89, p-value 0.057).
Conclusion Although BSIs with radiograph-negative ankle injuries are generally treated with cast immobilization, in this cohort only 13.9% had a high level of suspicion of SH1. Lateral malleolus tenderness was associated with a high level of suspicion of SH1 injury, but none of the clinical variables had a significant predictive value.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Board of VieCuri Medical Centre waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors.
